[image_with_animation image_url= »9989″ animation= »Fade In » hover_animation= »none » alignment= »center » border_radius= »none » box_shadow= »none » image_loading= »default » max_width= »100% » max_width_mobile= »default » img_link= »https://www.microbiometimes.com/fda-lifts-hold-on-maat-pharmas-phase-3-investigational-nda-for-maat013-in-patients-with-acute-graft-versus-host-disease/ »]